ClassID:

242628

Y10S514/866 - page 2 - CPC Classification

Classification description:

Recent Application in this class:
#301
20050101537
2005-05-12

Use of exendins and agonists thereof for lowering plasma lipid

#302
20050100614
2005-05-12

Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

#303
20050090555
2005-04-28

Compound for the treatment of metabolic disorders

#304
20050079203
2005-04-14

Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders

#305
20050079177
2005-04-14

Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases

#306
20050075396
2005-04-07

Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia

#307
20050075379
2005-04-07

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

#308
20050065108
2005-03-24

Antidiabetic 2-substituted-5′-O-(1-Boranotriphosphate) adenosine derivatives

#309
20050065074
2005-03-24

Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes

#310
20050063991
2005-03-24

Therapeutic uses of powder

#311
20050059711
2005-03-17

Potentiators of insulin secretion

#312
20050059601
2005-03-17

Exendins, exendin agonists, and methods for their use

#313
20050059119
2005-03-17

Method for making human insulin precursors

#314
20050058624
2005-03-17

Chimeric IL-10 proteins and uses thereof

#315
20050054685
2005-03-10

Pharmaceutical composition

#316
20050049203
2005-03-03

Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor

#317
20050043362
2005-02-24

Use of compounds

#318
20050043281
2005-02-24

2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds

#319
20050043249
2005-02-24

Pyrazole derivatives and diabetic medicine containing them

#320
20050043238
2005-02-24

Exendins and exendin agonists for weight reduction and obesity

#321
20050037997
2005-02-17

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

#322
20050037980
2005-02-17

Substituted fused heterocyclic C-glycosides

#323
20050037958
2005-02-17

Inotropic and diuretic effects of GLP-1 and GLP-1 agonists

#324
20050037003
2005-02-17

Methods for inhibiting lymphotoxin β receptor signalling

#325
20050019409
2005-01-27

Gastric retention dosage form having multiple layers

#326
20050014703
2005-01-20

Method for the improvement of islet signaling in diabetes mellitus and for its prevention

#327
20050009909
2005-01-13

Carboxylic compound and medicine comprising the same

#328
20050008716
2005-01-13

Synergistic composition for the treatment of diabetes mellitus

#329
20050004115
2005-01-06

Compounds for the treatment of metabolic disorders

#330
20050004082
2005-01-06

Ether compounds

#331
12697537
2015-08-11

Adult and neonatal stem cell therapy to treat diabetes through the repair of the gastrointestinal tract